COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

被引：0
|
作者：
Anne H. Cross
Silvia Delgado
Mario Habek
Maria Davydovskaya
Brian J. Ward
Bruce A. C. Cree
Natalia Totolyan
Ratnakar Pingili
Linda Mancione
Xixi Hu
Roseanne Sullivan
Wendy Su
Ronald Zielman
Ayan Das Gupta
Xavier Montalban
Kevin Winthrop
机构：
[1] Washington University,Department of Neurology
[2] University of Miami Miller School of Medicine,Infectious Diseases Division
[3] University Hospital Center Zagreb,UCSF Weill Institute for Neurosciences, Department of Neurology
[4] University of Zagreb,Department of Neurology
[5] School of Medicine,Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat)
[6] Moscow State Public Healthcare InsCity Clinical Hospital 24,undefined
[7] Research Institute of the McGill University Health Centre,undefined
[8] University of California San Francisco,undefined
[9] First Saint Petersburg State Medical University,undefined
[10] Novartis Pharmaceuticals Corporation,undefined
[11] Novartis Pharma B.V.,undefined
[12] Novartis Healthcare Private Limited,undefined
[13] Hospital Universitari Vall d’Hebron,undefined
[14] School of Public Health at Oregon Health and Science University,undefined
来源：
Neurology and Therapy | 2022年 / 11卷
关键词：
ALITHIOS; Anti-CD20 therapy; B-cell therapy; COVID-19; Ofatumumab; Post-marketing; Relapsing multiple sclerosis; SARS-CoV-2; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 758
页数：17
相关论文
共 50 条
  • [41] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Amir Hadi Maghzi
    Maria K. Houtchens
    Paolo Preziosa
    Carolina Ionete
    Biljana D. Beretich
    James M. Stankiewicz
    Shahamat Tauhid
    Ann Cabot
    Idanis Berriosmorales
    Tamara H. W. Schwartz
    Jacob A. Sloane
    Mark S. Freedman
    Massimo Filippi
    Howard L. Weiner
    Rohit Bakshi
    Journal of Neurology, 2020, 267 : 2790 - 2796
  • [42] COVID-19 in Cladribine-treated patient with multiple sclerosis
    Haham, Nitsan
    Vaknin-Dembinsky, Adi
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 359
  • [43] COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
    Buttari, Fabio
    Bruno, Antonio
    Dolcetti, Ettore
    Azzolini, Federica
    Bellantonio, Paolo
    Centonze, Diego
    Fantozzi, Roberta
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [44] COVID-19 in teriflunomide-treated patients with multiple sclerosis
    Maghzi, Amir Hadi
    Houtchens, Maria K.
    Preziosa, Paolo
    Ionete, Carolina
    Beretich, Biljana D.
    Stankiewicz, James M.
    Tauhid, Shahamat
    Cabot, Ann
    Berriosmorales, Idanis
    Schwartz, Tamara H. W.
    Sloane, Jacob A.
    Freedman, Mark S.
    Filippi, Massimo
    Weiner, Howard L.
    Bakshi, Rohit
    JOURNAL OF NEUROLOGY, 2020, 267 (10) : 2790 - 2796
  • [45] Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab
    Kintrilis, Nikos
    Gkinos, Charilaos P.
    Galinos, Iosif
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [46] COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis
    Hernandez-Garcia, Ignacio
    Rodriguez-Montolio, Joana
    Almeida-Zurita, Monserrath
    Cheli-Gracia, Dionisio
    Sahuquillo, Belen del Moral
    Aibar-Remon, Carlos
    Garces-Redondo, Moises
    VACCINES, 2024, 12 (02)
  • [47] Summary of safety and efficacy of COVID-19 vaccination in patients with multiple sclerosis
    Pernicova, Eva
    Macounova, Petra
    Krsek, Martin
    Mad'ar, Rastislav
    EUROPEAN NEUROLOGY, 2023, 86 (04) : 263 - 276
  • [48] Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
    Fioravante Capone
    Matteo Lucchini
    Elisabetta Ferraro
    Assunta Bianco
    Mariagrazia Rossi
    Alessandra Cicia
    Antonio Cortese
    Alessandro Cruciani
    Valeria De Arcangelis
    Laura De Giglio
    Francesco Motolese
    Biagio Sancetta
    Massimiliano Mirabella
    Vincenzo Di Lazzaro
    Neurotherapeutics, 2022, 19 : 325 - 333
  • [49] MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
    Yamout, Bassem, I
    Zakaria, Magd
    Inshasi, Jihad
    Al-Jumah, Mohammad
    Zeineddine, Maya
    Dahdaleh, Maurice
    Bohlega, Saeed
    Gouider, Riadh
    Alroughani, Raed
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [50] Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
    Capone, Fioravante
    Lucchini, Matteo
    Ferraro, Elisabetta
    Bianco, Assunta
    Rossi, Mariagrazia
    Cicia, Alessandra
    Cortese, Antonio
    Cruciani, Alessandro
    De Arcangelis, Valeria
    De Giglio, Laura
    Motolese, Francesco
    Sancetta, Biagio
    Mirabella, Massimiliano
    Di Lazzaro, Vincenzo
    NEUROTHERAPEUTICS, 2022, 19 (01) : 325 - 333
12345